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Abstract 
The purified H2-uptake hydrogenase of Bradyrhizobium japonicum, containing no cytochrome b, catalyzed efficient H2-ubiquinone 
oxidoreductase activity. Hydrogen-oxidizing membranes also catalyzed H2-ubiquinone oxidoreductase activity, and the site of ubiquinone 
reduction was localized to the He-quinone oxidoreductase complex based on comparative antimycin A and HQNO titrations of both 
H2-ubiquinone-1 oxidoreductase and ubiquinol-1 oxidase activities. A variety of quinones could function as electron acceptors of both 
pure or membrane-bound hydrogenase, including ubiquinone-0 (Qo), ubiquinone-1 (Q1), duroquinone and menadione, indicating 
relatively loose substrate specificity with regard to the quinone head group. Both the redox potential and the quinone structure determined 
the efficiency of hydrogenase turnover. Among short-chain ubiquinones, the isoprenoid chain length had a profound affect on Kin, with 
each additional isoprenoid unit resulting in the K m of the membrane-bound e zyme to decrease more than an order of magnitude. For 
pure enzyme, the K m values for Q0, Q1 and Q2 were 1.97 mM, 68.8 /xM and 3.1 /~M, respectively. Vma x was also influenced by the 
substrate isoprenoid chain length for the pure enzyme. The inhibition patterns of H2-dependent Q1 versus MB reduction by the quinone 
analogs (2-n-heptyl-4-hydroxyquinoline N-oxide and Antimycin A) were significantly different, and clear differences in pH optima for 
the two activities were observed. In addition, the two hydrogen-dependent electron acceptor activities (Q1 and MB) exhibited ifferent 
time-dependent inactivation patterns by the chemical modification reagent diazobenzene sulfonate. Ubiquinone and MB therefore react by 
different mechanisms (perhaps at different sites) within the hydrogenase complex in situ. The inhibition pattern of hydrogen-ubiquinone 
oxidoreductase activity by antimycin A was clearly different than antimycin A inhibition of ubiquinol oxidation at the bc I complex. This 
is, to our knowledge, the first report of antimycin A inhibition of a hydrogenase complex, and also of a quinone reducing site of a primary 
dehydrogenase. When pure hydrogenase is assayed in the absence of dithionite, a delay (lag phase) is observed prior to attainment of full 
activity. The length of this lag period (in minutes) was inversely dependent on ubiquinone concentration, and was greatly reduced (but not 
eliminated) atsaturating ubiquinone l vels. These effects were obtained with both Q1 and MB as electron acceptor, and the lag phases 
with Q1 were significantly longer than with MB. Electron acceptor binding to hydrogenase is thus required for reductive activation of 
hydrogenase during turnover. 
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1. Introduction 
Hydrogenases are a diverse group of H2-activating en- 
zymes which occur in a variety of prokaryotic organisms 
[1-3]. A large subset of these enzymes, the NiFe-hydro- 
genases, contain two subunits, one each of approx. 65 and 
33 kDa, and Ni and two or three Fe-S clusters as prosthetic 
groups. The NiFe-hydrogenases from diverse species of 
aerobic N2-fixing bacteria, aerobic H2-oxidizing bacteria, 
purple non-sulfur bacteria, green sulfur bacteria, meth- 
ylotrophs, enteric bacteria, and sulfate-reducing bacteria 
have been shown to be immunologically related [4-7]. The 
structural genes encoding the membrane-bound hydroge- 
nase from many of these bacteria have been sequenced and 
show a high degree of homology (see [8] and [9] for 
reviews). Membrane-bound NiFe-hydrogenases generally 
couple H2-oxidation to an energy-generating, membrane- 
bound electron transport chain. A lipophilic quinone func- 
tions in electron transport between hydrogenase and the 
terminal reductase in these electron transport chains; the 
specific quinones used (menaquinone, ubiquinone, or 
plastoquinone) varies with the particular system [10-13]. 
The identity of the specific redox components function- 
ing between H 2 and quinone in these organisms remains 
controversial. In the aerobic, N2-fixing bacterium 
Bradyrhizobium japonicum we have recently demonstrated 
efficient H2-ubiquinone oxidoreductase activity by purified 
heterodimeric hydrogenase, containing no detectable cy- 
tochromes. The enzyme catalyzed H2-Q ~ oxidoreductase 
activity at rates up to 47% of H2-1inked MB reducing 
activity [14] and was the first direct demonstration of 
H2-ubiquinone oxidoreductase activity by a purified hy- 
drogenase. However, H2-1inked quinone reduction was 
demonstrated in a trimeric hydrogenase complex from the 
anaerobic rumen bacterium Wolinella succinogenes. In 
addition to a 60 kDa large subunit and a 30 kDa small 
subunit, this complex contained a b-type cytochrome. The 
cytochrome b of the complex was proposed to be the 
direct electron donor to menaquinone, since H2-dependent 
reduction of the cytochrome b and the menaquinone ana- 
log DMN was observed [15]. Previous proposals for the 
possible direct electron acceptor of membrane-bound hy- 
drogenases include ubiquinone [11,13], cytochromes [16- 
18] and an unidentified electron carrier [19]. The proposed 
involvement of all of these carriers were based on experi- 
ments with membrane vesicles containing many redox-ac- 
tive components, rather than with purified or reconstituted 
systems, so the direct electron acceptor from hydrogenase 
has not been rigorously identified. 
Many membrane-bound heterodimeric NiFe hydroge- 
nases, including the B. japonicum enzyme, have been 
purified and extensively studied using artificial electron 
acceptors uch as MB [1-3,20-22], the most commonly 
used electron acceptor for hydrogenase assays. Because of 
the lack of available information on the H2-quinone oxido- 
reductase reaction and the likelihood that it represents a 
more 'physiological' reaction as compared with the H 2-MB 
oxidoreductase reaction, it is important to characterize and 
compare the two reactions by both membranes and puri- 
fied hydrogenase. Here we present data which indicate that 
both the redox potential and structure of quinones play a 
role in determining the substrate specificity of different 
quinones with hydrogenase. In addition, H2-dependent re- 
duction of ubiquinone and MB behave differently with 
respect o pH optima and inhibition by quinone analogs, 
and the two activities were differentially inactivated by 
chemical modification with DABS. These results indicate 
that MB and ubiquinone react by different mechanisms 
with the hydrogenase complex in situ. Finally, experiments 
on H2-dependent activation of purified hydrogenase during 
turnover demonstrated that the electron acceptor concentra- 
tion dictates the delay period (lag phase) required to 
achieve maximal rates ot both (H2-dependent) ubiquinone 
and MB reduction. The length of the lag phase is signifi- 
cantly decreased at saturating levels of electron acceptor, 
demonstrating that acceptor binding is a necessary step in 
hydrogenase activation during turnover. 
2. Materials and methods 
2.1. Bacterial strains and culture conditions 
B. japonicum strain SR473, an EMS-induced regulatory 
mutant which expresses hydrogenase constitutively [23], 
was grown aerobically and heterotrophically at 29 ° C. Cells 
were grown in 15-liter batches to a density of (6-8).  108 
cells/ml in modified Bergerson's medium [24] supple- 
mented with 5 /zM NiC12 [25], and washed in 50 mM 
potassium phosphate, 2.5 mM MgCI 2 (pH 7.0). Cells were 
used immediately for membrane preparations and stored at 
- 80 ° C for hydrogenase preparations. The hydrogenase in 
these cells is indistinguishable from the enzyme in dere- 
pressed wild-type cells [25]. 
2.2. Preparation of membrane vesicles 
Membrane vesicles were prepared from 15 L batches of 
freshly harvested and washed cells as previously described 
[26]: Membranes were aliquotted and rapidly frozen, and 
stored in liquid N 2. Membranes stored in this way retained 
over 95% of their H 2 uptake activity to 0 2 over a period 
of months. Membranes were kept at 0 ° C under Ar during 
experiments. 
2.3. Purification of hydrogenase 
Hydrogenase was solubilized from extracts of 15-30 g 
of heterotrophically grown cells and purified aerobically as 
previously described [25]. All buffers contained 0.2-1.0 
mM PMSF. The eluate of the Reactive Red 120-agarose 
column was concentrated by ultrafiltration using an Ami- 
336 D.M. Ferber et al. / Biochimica et Biophysica Acta 1229 (1995) 334-346 
con concentrator with a YM-10 membrane, rapidly frozen 
and stored in liquid N 2. Hydrogenase stored this way was 
stable for 1 year. The apparent quality of the purified 
preparation affected the delay period (lag phase) required 
to reach full activity (Fig. 7); the lag phase for pure 
hydrogenase was somewhat variable from preparation to 
preparation, ranging from 5 to 12 min under identical 
assay conditions with 200 /zM Q1 as electron acceptor. It 
is noteworthy that preparations with higher specific activi- 
ties showed short lag phases upon assay. 
2.4. Measurement of H 2 and 0 2 uptake 
H 2 and 0 2 were measured simultaneously amperomet- 
rically. A model YSI-5331 Clark-type 0 2 electrode (Yel- 
low Springs Instruments, Yellow Springs, OH) was used 
for amperometric 0 2 measurement and modified for am- 
perometric H 2 measurement [27,28]. The H 2 electrode 
preconditioning protocol and interfacing circuitry for both 
electrodes were modified from that previously devised for 
use with the YSI-4004 02 electrode [27], which was 
discontinued by the manufacturer. In order to precondition 
the probe for H 2 measurement, AgC1 is deposited on the 
Ag electrode by immersing the tip in 0.1 M HC1 and 
applying a voltage of + 9 V from a battery for approx. 30 
min. During this procedure, H 2 bubbles rapidly from the 
tip of the Pt electrode. Electrode lifetime is adversely 
affected by prolonged periods of preconditioning. The 
electrode is then assembled as per manufacturer's instruc- 
tions and inserted into the experimental chamber; baseline 
equilibration occurs over approx. 1 h. Unlike the previ- 
ously described protocols for H 2 measurement using the 
YSI-4004 electrode, no initial pretreatment with H 2 gas is 
necessary to increase electrode sensitivity or decrease re- 
sponse time; in fact, such treatment actually decreases the 
sensitivity of the electrode. 90% of full response is attained 
in 10 s; full response occurs over 60-90 s. The signal is 
quite stable except for slow leakage of H 2 from the 
chamber (< 5% over 10 min); this background rate was 
subtracted in order to normalize the H 2 consumption rates. 
The signal is linear with H 2 concentrations from 0.4 /xM 
to 100 /zM in solution. 
H 2 uptake assays with quinones or MB as electron 
acceptors were conducted as previously described [14]. All 
activities were calculated from the linear phase on the H 2 
uptake progress curve [14]. One unit represents 1 
/xmol/min/mg. Assays with 0 2 as electron acceptor (H 2- 
0 2 activity or QIH2-O2 activity) were done under mi- 
croaerobic onditions (15-30 /xM O2); maximal evels of 
H2-O 2 activity were observed under these conditions (data 
not shown). Buffer was sparged with Ar at a constant rate 
during the course of an experiment, then transferred 
(without introducing air bubbles) to the chamber, which 
was immediately sealed. 0 2 levels (monitored amperomet- 
rically) varied less than 5 /xM during the course of an 
individual experiment. For Q1H2 oxidase assays 200 /.,M 
Q1 was reduced by 2.0 mM dithioerythritol during the 
assay. 
2.5. Inhibition by quinone analogs 
Components were added to the assay buffer [14] com- 
posed of 50 mM potassium phosphate, 2.5 mM MgC12 (pH 
6.2) in the following order: sample, glucose oxidase and 
catalase, glucose, H 2 (10.8 /xM), NaCN (250 /xM) and 
inhibitor. Reactions were initiated immediately by addition 
of electron acceptor. Inhibitors were added as ethanolic 
aliquots, such that the total concentration of ethanol was 
less than 1%. This concentration of ethanol did not effect 
H 2 uptake rates by membranes or pure hydrogenase. 
HQNO was soluble in the assay buffer at all concentra- 
tions used; antimycin A was partially insoluble above 150 
/zM. The antimycin A used in these experiments i  a 
mixture of the A 1 and A 3 isomers. 
2.6. H2-ubiquinone kinetics 
Various soluble and hydrophobic ubiquinone homologs 
were studied in steady-state kinetics experiments in order 
to determine their K m and Vma x values. A single prepara- 
tion of enzyme or membranes was used for these experi- 
ments in order to avoid variation in specific activity among 
different preparations. All assays were done as previously 
described, using the glucose oxidase system to remove 02 
[14]. NaCN (250 /xM) was present in all assay mixtures; 
and assay mixtures were identical for membranes and 
purified hydrogenase. NaCN inhibits > 98% of O2-1inked 
H 2 uptake in membranes (data not shown), thus all H 2 
uptake measured was due to quinone reduction. H 2 uptake 
rates were calculated from the linear phase of H 2 uptake 
(following the non-linear lag period of reductive activa- 
tion) and data were fit to the Michaelis-Menten equation 
[O] Vmax 
V= 
(K  m -t- [Q]) 
by non linear least-squares regression. Non-linear egres- 
sion was done with the curve-fitting function of SigmaPlot 
(Jandel Scientific, Corte Madera, CA), which uses the 
Marquardt-Levenberg al orithm. 
2.7. pH optima determination and chemical modification 
experiments 
H2-Q 1 or H2-MB oxidoreductase activity was assayed 
in membranes or purified hydrogenase as described above 
(Section 2.4), except hat the buffer was 25 mM Mes, 25 
mM Hepes, 25 mM Tris and 25 mM glycine adjusted to 
the appropriate pH (4.5-9.0) with HC1 or NaOH. All 
points represent averages of two or three determinations. 
The chemical modification experiments using DABS were 
performed exactly as described [29], except that samples 
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were incubated at 0°C for 10 min rather than 5 min prior 
to initiation of the modification reaction by the addition of 
DABS. DABS was synthesized as previously described 
[30] and stored in aliquots at - 80 ° C. DABS was used at a 
final concentration of 1.0 mM, in 50 mM potassium 
phosphate (pH 8.0). Membranes were diluted at least 1:3 
from their storage buffer (Buffer B in Ref. [14]) and 
activities (HE-Q 1 or HE-MB) were determined as described 
above at different ime points. 
2.8. Synthesis of ubiquinone-2 
Ubiquinone-2 (Q2) was synthesized by a modification 
of a previously described method [31]. The modifications 
were as follows: [1] diethyl ether was treated with FeC12 to 
remove peroxides prior to use, [2] following reaction of 
QoH2 with linalool, the reaction mixture was diluted in 
150 ml diethyl ether and washed six times with 50 ml of 
5% NaHCO 3. In addition, following the washing and 
drying steps, the product was purified by preparative chro- 
matography over two successive Silica-gel 60 (Whatman) 
columns developed in hexanes/diethyl ether (5:1, v /v )  
and toluene/acetone (97:3, v /v) ,  respectively. Column 
fractions were identified by analytical thin-layer chro- 
matography on silica gel (Whatman K5) in an optimized 
solvent system of toluene/acetone (97:3, v /v) ,  which 
cleanly separated Q1, the product and Q4 (data not shown). 
The product migrated with an intermediate R v between Q1 
and Q4: RF values for Q1, product and Q4 were 0.38, 0.44 
and 0.52, respectively. Ubiquinones were identified on the 
TLC plates by their yellow color, and purity of the product 
was confirmed by 12 staining. The identity of the product 
as a ubiquinone was confirmed by UV/visible redox 
difference spectrophotometry (NaBHa-reduced minus air- 
oxidized); the concentration of the product was calculated 
using Aered_ox ' 278 300 = 10.6 mM -t  cm- t  [32], assuming 
the Q2 had a Aered_ox ' 278 300 identical to that of Qr  The 
product was further identified by fast-ion bombardment 
mass spectrometry (m/z  of the product, 319; correspond- 
ing to C19H2704 ).
obtained from Linde Gases of Baltimore, Baltimore, MD. 
All other chemicals were of reagent grade and were ob- 
tained from Sigma or J.T. Baker Chemical Co., Phillips- 
burg, NJ. 
3. Results 
3.1. HE-dependent ubiquinone reduction in membranes 
occurs at the hydrogenase complex 
HE-Q 1 oxidoreductase activity is catalyzed by both 
purified heterodimeric HE-uptake hydrogenase (containing 
no cytochrome b) and membrane vesicles from B. japon- 
icum [14]. In order to characterize and compare the n 2- 
quinone oxidoreductase activity of the in situ hydrogenase 
complex with that of purified hydrogenase, it was impor- 
tant to ascertain that exogenous Q1 is actually reduced at 
the hydrogenase complex in situ. B. japonicum contains a 
cytochrome bc 1 complex which is expressed in both bac- 
teroids and free-living cells, and mutants lacking this 
complex are deficient in HE-O 2 respiration (17% of the 
wild-type level) [34]. Although this complex catalyzes the 
net oxidation of one quinol molecule, the currently ac- 
cepted Q-cycle model for cytochrome bc 1 complex cataly- 
sis states that one molecule of quinone is reduced at center 
N of the complex for every two molecules of quinol 
oxidized at center P [35,36], thus it was possible that Q1 
reduction was occurring via center N of the cytochrome 
bc 1 complex. Q1 reduction at center N could thus occur by 
two different mechanisms, which were tested in separate 
experiments. In order to test the possibility of center 
N-dependent Q1 reduction, coupled to Q10H2 oxidation at 
center P, we tested for inhibition with myxothiazol, which 
specifically inhibits quinol oxidation at center P [35]. No 
inhibition of Q1 reduction was found by 20/xM myxothia- 
zol, despite the fact that the same concentrations of in- 
hibitor dramatically inhibited QIH2 - and HE-linked O 2 
uptake (see Table 1). Since myxothiazol inhibits 76% of 
the H 2-02 oxidoreductase activity and 96% of the QIH 2-02 
2.9. Protein determination 
Total protein was measured with a modified Lowry 
assay [33], using BSA as a standard. 
2.10. Chemicals and reagents 
Q1 and Q4 were kind gifts of Hoffman-LaRoche, Inc., 
Nutley, NJ. Q0, decyl-Q, Q10, menadione, duroquinone, 
vitamin K1, vitamin KE, DBMIB, DCMU, HQNO, an- 
timycin A (Catalog No. A-8674) and myxothiazol were 
obtained from Sigma; as were glucose oxidase (Type X-S), 
bovine liver catalase, DNase, PMSF, butylated hydroxy- 
toluenes. Linalool was obtained from Aldrich. Argon (type 
HP), nitrogen (type HP) and hydrogen (type PP) were 
Table 1 
Effect of myxothiazol on quinone reduction and quinol oxidation 
Assay Specific activity % Inhibition 
control myxothiazol a 
HE-Q 1 556+26 (3) 575+11 (3) -3.4 
HE-O 2 44+ 6.5 (3) 10.3+ 3.1 (4) 76.4 
Q1HE-O2 74+ 6.7 (3) 3.2+ 0.2 (3) 95.7 
H 2 and 02 uptake in membranes (86-172 /xg protein) were assayed 
amperometrically s described in Materials and Methods. Specific activi- 
ties (nmol/min/mg) are expressed as the mean 5: S.E. (n determinations). 
For HE-Q 1 activity H E uptake was assayed in the presence of200 /xM 
Q1. For HE-O 2 activity and ubiquinol (Q1H2) oxidation activity, oxygen 
uptake was monitored [14] microaerobically s described in Materials and 
Methods. Q1H2 (200 p.M) was reduced with 2.0 mM dithioerythritol 
a Myxothiazol was added to a concentration of 20 /zM. 
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activity, most electron flow to 0 2 probably proceeds 
through a myxothiazol-sensitive cytochrome bc~ complex. 
Since myxothiazol does not inhibit H2-1inked Q1 reduc- 
tion, reduction of Q1 at center N is not coupled to Qlo H2 
oxidation at center P. 
The second possible mechanism of Q1 reduction at the 
bc t complex involves a quinol-quinone transhydrogenation 
at center N via a ping-pong mechanism, as reported for the 
cytochrome bc 1 complexes from Neurospora crassa, 
bovine heart and potato [37-39]. This possibility was 
tested by performing separate titrations of H2-dependent 
Q1 reduction and Q]H2-O2 oxidoreductase activities with 
inhibitors HQNO and antimycin A. These inhibitors effec- 
tively inhibited H2-Q 1 oxidoreductase activity of B. japon- 
icum membranes ( ee below and [14]), and inhibit center N 
but not center P of the bc  I complex [40]. If H2-1inked Q1 
reduction occurred at center N, then inhibitor titration 
curves of H2-Q 1 and Q1H2-O2 activities hould be very 
similar. The results indicated, however, that inhibitory 
concentrations of both antimycin and HQNO were signifi- 
cantly lower for QIH2-O2 oxidoreductase activity than for 
H2-Q ~ activity (Fig. 1). For the inhibitor Antimycin A the 
150 for QIH2-O2 activity was approximately three orders 
of magnitude less than that for H2-Q ~ (about 10 -9 VS. 
10 -6,  Fig. 1A) and one order of magnitude less with 
HQNO (about 5 .10  -8 vs. 5 .10  -7,  Fig. 1B). All these 
results, taken together, indicate that H2-1inked Q~ reduc- 
tion occurs 'upstream' of the center N of the bc I complex; 
and the most likely site is an antimycin- and HQNO-sensi- 
tive site on the hydrogenase complex. 
3.2. Specificity of H2-quinone oxidoreductase activity 
Various quinones were tested as electron acceptors with 
purified hydrogenase and with membranes. The activities 
with different quinones were compared to the rates with 
MB, which is the most effective artificial electron acceptor 
for both membranes and purified hydrogenase. The 
ubiquinones Q0 and Q1, menadione (MK 0) and the plasto- 
quinone analog duroquinone all functioned effectively as 
electron acceptors with membranes (Table 2), although 
activity to duroquinone was approximately half the others 
at the two concentrations tested. Phylloquinone was essen- 
tially an ineffective substrate, and MK 4 functioned poorly 
as a substrate; these quinones had the lowest midpoint 
potentials (see Table 2). Q4 functioned effectively as 
electron acceptor with membranes: its Vma x of 0.12 
/xmol/min per mg (data not shown), was 39% that of the 
maximal rate for Q1 reduction by membranes (Table 3). A 
similar pattern of substrate specificity was observed with 
purified hydrogenase. However, duroquinone and mena- 
dione were significantly more effective as electron accep- 
tors with pure hydrogenase than with membranes, relative 
to QI" In addition, only low levels of activity were ob- 
served with pure hydrogenase using 400 /xM Q0 as elec- 
tron acceptor, in contrast to the situation with membranes. 
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Fig. 1. Differential inhibitor titrations of H2-Q 1 and Q1H2-O2 oxido- 
reductase activities. H 2 uptake activity (11) was assayed amperometri- 
cally with Q1 (200 /zM) as electron acceptor, and 02 uptake (O) was 
assayed amperometrically with Q1H2 as electron donor, as described in 
Experimental Procedures. H2-Q 1 oxidoreductase assays were initiated by 
addition of Qr Q1H2"O2 oxidoreductase assays were conducted under 
microaerobic conditions ([02] = 15-30 /~M) and initiated by addition of 
dithioerythritol (2 mM). Inhibitors were added from stock solutions in 
ethanol immediately before assay. (A) Inhibition by antimycin A. Assay 
mixtures (H2-Q 1) contained 210/xg membranes, and uninhibited specific 
activity (H2-Q 1) was 0.95 /zmolmin -1 mg-1 (B) Inhibition by HQNO. 
Assay mixtures (QIH2-O2) contained 2.1 mg of membranes, and uninhib- 
ited specific activity (Q 1H 2-O 2 ) was 42.5 nmol min - 1 mg - l. 
This is undoubtedly due to the high K m (2.0 mM) for Q0 
by pure enzyme (Table 3). No activity was observed with 
pure hydrogenase using Q4 or Q10 as an electron acceptor 
(data not shown). 
3.3. Kinetic characterization of activity with different 
quinone homologs 
Initial investigations of H2-quinone oxidoreductase ac- 
tivity by hydrogenase howed that the apparent Krn for Q1 
was much lower than that for Q0. Due to this difference, 
and the observed quinone-dependent specific activity dif- 
ferences in H2-1inked quinone reduction (for both purified 
hydrogenase and membranes) (Table 2), we further exam- 
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Table 2 
Effectiveness ofdifferent quinones as electron acceptors 
339 
Electron E~ Concentration Specific activity 
acceptor (/.~M) membranes pure enzyme 
(nmol/min per rag) (/zmol/min per rag) 
Q1 +110 80 117_+ 4 1.2 _+0.9 
400 198_+ 5 5.1 _+0.2 
Q0 + 162 80 111 _+ 4 n.d. 
400 197 -+ 7 0.13 -+ 0.01 
Duroquinone + 5 80 57___ 3 1.5 _+0.1 
400 102_+ 7 3.7 _+0.1 
Menadione - 1 80 113_+ 10 7.6 _+0.2 
400 212 _+ 26 10.6 _+ 1.0 
Phylloquinone - 50 400 1.6 _+ 1.0 0.02 _+ 0.01 
Menaquinone-4 - 72 80 6.0 _+ 5.1 0.01 _+ 0.0 
400 12.2 _+ 3.8 
MB + 11 180 1144_+88 9.8 _+0.7 
Membranes (29.5 /xg protein) or pure enzyme (4.5 /xg protein) were assayed amperometrically t 25 ~ C. Specific activity of membranes with 15-30 /.~M 
0 2 was  44.5 nmolmin -1 mg -1. The values are the means -+ S.E. of four determinations. 
ined the steady-state kinetic parameters of hydrogenase for 
a number of ubiquinones that varied in their isoprenoid 
chain length. K m and Vm~ x values for Qo, Q1 and Q2 were 
determined for both the pure enzyme or membranes by 
steady-state kinetic experiments. Among the short-chain 
ubiquinones Qo, Q1 and Q2, isoprenoid chain length was 
found to have a profound effect on the K m (Table 3). With 
membranes, each additional isoprenoid unit caused the K m 
to decrease approximately an order of magnitude. Vm~ x, 
however, was largely independent of chain length, with the 
exception that Q2 had an approx. 2-fold higher Vmx than 
Q1. Even more dramatic effects of isoprenoid chain length 
on K m were observed with purified hydrogenase. The K m 
for Q1 was 22-fold higher than that for Q2; and the g m for 
Q0 was 28-fold higher than that for Q1 (Table 3). Unlike 
the case of membranes, however, the Vma x with purified 
hydrogenase was greatest using Q1 as the electron accep- 
tor; it was 7-fold higher than the Vma x for Q0- The gra for 
Q4 with membranes was estimated at 0.063 /zM, and no 
activity with Q4 was observed with pure hydrogenase (data 
not shown). 
Q~ was used as electron acceptor for additional investi- 
gations of Hz-quinone oxidoreductase activity, because of 
its high solubility, low K m and high Vma X. The latter two 
properties suggest that it reacts as the physiological 
ubiquinone binding site. In order to relate H2-ubiquinone 
oxidoreductase to the previous studies of hydrogenase 
which used other electron acceptors, both H2-Q 1 and 
H 2-MB oxidoreductase activities were compared in several 
biochemical parameters. 
3.4. pH optima for H 2 oxidation 
Initially, the pH dependence of H2-Q 1 and H2-MB 
oxidoreductase were investigated. For membranes, H2-MB 
activity was observed over a broad pH range from 4 to 9, 
with an optimum at pH 6.5, while H2-Q 1 activity showed a 
somewhat narrower ange of activity and an optimum pH 
of 7.0 (Fig. 2A). Oxygen-dependent H 2 oxidation activity 
in B. japonicum membranes has been previously shown to 
have an optimum pH of approx. 7.2 [41], similar to the 
value obtained for HE-Q 1 activity. Like the membranes, 
purified hydrogenase demonstrated significantly different 
pH optima for HE-Q 1 and HE-MB activities. HE-Q 1 and 
HE-MB activities showed pH optima of 5.5 and 6.0, 
respectively. High levels of H2-Q 1 activity were observed 
at pH 4.5-5.0, where virtually no H2-MB activity was 
observed (Fig. 2B). The difference in pH optimum with Q1 
Table 3 
Steady-state kinetics of H2-ubiquinone oxidoreductase activity 
Ubiquinone Membranes Pure hydrogenase 
K m (/xM) Vma x(O/mg) K m (~M) Vma x(U/mg) 
Q0 30.5 +5.2 0.30+0.03 1974 +31 0.71 +0.04 
Q1 2.9 +0.3 0.31+0.02 68.8+ 13.9 5.2 +0.5 
Q2 0.44 + 0.08 0.64 + 0.04 3.1 + 1.2 2.1 +0.4 
Results were determined by non-linear least-squares regression to the Michaelis-Menten quation, as described in 'Materials and Methods,' and are 
expressed as mean + S.D. Results are representative of at least wo independent experiments. 
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Fig. 2. pH optima for H 2 uptake activity with Q1 and MB. Membranes 
(A, 52 /~g) or purified hydrogenase (B, 1.6-5.5 /.~g) were assayed 
amperometrically in 25 mM Mes, 25 mM Hepes, 25 mM Tris, 25 mM 
glycine at the stated pH. H 2 uptake by membranes was assayed with Q~ 
(100 /xM, O) or MB (180 /zM, v). H 2 uptake by purified hydrogenase 
was assayed with Qz (250 /zM, ~)  or MB (180 /zM, v). Points 
represent the average of two or three determinations. 
or MB as electron acceptors may be due to different 
mechanisms of electron transfer to the two electron accep- 
tors; this is most easily explained by reaction of the 
electron acceptors at separate binding sites. This possibi l ity 
was further examined by the use of inhibit ion and chemi- 
cal modif ication experiments. 
3.5. Inhibition of H 2 uptake by quinone analogs 
Since HQNO and antimycin significantly inhibited Q1- 
dependent H E uptake, we tested the effects of other in- 
hibitors which are known to inhibit at quinone binding 
sites. However, DBMIB,  DCMU,  and myxothiazol (all 
tested at 50 /zM) did not inhibit HE-Q 1 oxidoreductase 
activity. Inhibit ion by HQNO and antimycin were then 
characterized in more detail. Inhibit ion of H2-Q 1 oxido- 
reductase activity by HQNO was observed at saturating 
(200 /xM) and sub-saturating (10 /xM) Q1 concentrations 
(Fig. 3). Maximal inhibit ion was about 80%. A very 
similar inhibit ion profile was observed for H2-O 2 activity 
(Fig. 3). In contrast, H 2 uptake to MB was not inhibited, 
consistent with previous observations with free-l iving cells 
[42] and root nodule bacteroids [43]. Indeed, in our experi- 
ments, HQNO was consistently found to enhance H2-MB 
oxidoreductase activity in membranes by 30-40%;  this 
enhancement was dependent on inhibitor concentration 
(Fig. 3). The concentration dependence of this activation 
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Fig. 3. HQNO inhibitor titration of H 2 uptake by membranes. H 2 uptake 
in membranes was assayed amperometrically with 02 (15-30 /.tM, O), 
Q] (10 tzM, v, or 200 /xM, v)  or MB (12 /xM, D, or 180 /.tM, m) as 
electron acceptor. HQNO was added from stock solutions in ethanol 
immediately before assay. Reaction mixtures contained 28.4 /zg mem- 
branes for assays with MB (180 /zM), and 56.7 /xg for other assays. 
Reactions were initiated by the addition of electron acceptor (Q1 or MB) 
or H 2 (for H2-O 2 activity assays). Uninhibited specific activity of 
membranes was 0.186 /.Lmolmin-1 mg 1 (H2_O2); 0.56 
/zmolmin -1 mg -1 (Hz-10 /.tM Q1); 3.38 /zmolmin-1 mg -1 (H2-200 
/zM Q1); 1.81 /zmolmin-lmg -1 (H2-12 /zM MB); and 7.07 
/xmolmin -1 mg -1 (H2-180 p.M MB). 
effect and HQNO inhibit ion of H2-O 2 and H2-Q 1 activities 
were very similar (Fig. 3). 
Inhibit ion experiments on H 2 uptake were also per- 
formed with Ant imycin A (Fig. 4). Efficient inhibit ion of 
membrane-bound H2-Q 1 and H2-O 2 oxidoreductase activi- 
ties were observed with this inhibitor with an 150 similar to 
that observed with HQNO (about 0.5 /zM). The maximal 
inhibit ion observed was also approximately the same as 
120 , r a , i , i • i • 
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Fig. 4. Antimycin A inhibition of H2-Q 1 oxidoreductase activity by 
membranes. Inhibitor was added to membranes (20 /zg protein) immedi- 
ately prior to the addition of H2, and the reaction was initiated by the 
addition of electron acceptor (Q1, 02, or MB). Uninhibited H e uptake 
was 0.31 /zmolmin- 1mg-1 with 0 2 (15-30 /zM), 0.44 
/zmolmin -] mg -1 with Q1 (10 /~M), and 0.62 /zmolmin ] mg -1 with 
MB (18 /zM). (O), H2-O 2 activity (v), H2-Q 1 activity; (Ill) H2-MB 
activity. 
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with HQNO (70-80%) (Fig. 3), although Antimycin A is 
insoluble in this assay system at concentrations above 100 
/zM. Antimycin, like HQNO, clearly did not inhibit H2-MB 
activity in membranes (Fig. 4), but no activation was 
observed. 
When HQNO-dependent inhibition of H2-Q 1 and H 2- 
MB activities by purified hydrogenase were examined by 
similar titration experiments, very different inhibition pro- 
files were observed as compared with the results for 
membrane-associated activity. With subsaturating electron 
acceptor concentrations (40/xM Q~ and 12/xM MB), both 
H2-Q ~ and H2-MB activities were significantly inhibited. 
However, much higher concentrations of HQNO (about 
200 ~M) were required for 50% inhibition of pure enzyme 
(Fig. 5) compared to the membrane-bound enzyme. 
3.6. Differential effects of the membrane-impermeant 
reagent DABS on H 2 uptake by membranes 
Although the results of the pH optima and inhibition 
experiments described above indicated that MB and Q~ 
react at different sites of hydrogenase in situ, more direct 
evidence was obtained by use of the chemical modification 
reagent DABS. DABS has previously been shown to cause 
a redox-dependent differential inactivation of H2-MB ac- 
tivity in B. japonicum membranes: activity is rapidly 
inactivated under a H2-containing atmosphere but not un- 
der an O2-containing atmosphere [29]. DABS-induced in- 
activation rates of the two acceptor (MB and Q~) activities 
were compared. H2-Q 1 activity exhibited redox-dependent 
differential inactivation similar to H2-MB activity: rapid 
and complete DABS-dependent inactivation was only ob- 
served when the membranes were H2-reduced in the ab- 
sence of O 2 (data not shown). However, when the DABS 
110 
I001 
°_  
> 
"-- 80 
o 70 
"o 60 
g)  
.D 5O 
¢" 40 
C 
o_  
(- 3O 
3 
20 
~R 
10 
0 
• i • i • i • i • i • i • i • i - i • i 
• i . | . | • i . i . t . i . i . i . i 
0 20  40  80  80  100120140180180200 
[HQNO] (pM) 
Fig. 5. HQNO inhibition of H 2 uptake by purified hydrogenase. H 2 
uptake by purified hydrogenase (3.3 p,g with MB, 8.2 /zg with Qt) was 
assayed amperometrically as described in Materials and Methods. HQNO 
was added immediately prior to assay and the reaction was initiated by 
the addition of electron acceptor. Uninhibited specific activity with Q1 
(40 p,M, O)  and MB (12 /xM, v )  as electron acceptor was 0.38 
p, molmin -1 mg -1 and 2.33 p, molmin - ]  mg -1, respectively. 
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Fig. 6. Differential DABS-induced inactivation of H2-Q 1 and H2-MB 
oxidoreductase activities in membranes. Membranes were diluted in 50 
mM potassium phosphate, 2.5 mM MgC12 (pH 8.0) as described in 
'Materials and Methods'; equilibrated under a gas phase of 90% Ar/10% 
O2; and treated with DABS (1.0 mM) under the same atmosphere. 
Aliquots (25 /xl or 50 /zl) were removed and assayed immediately at the 
indicated time points, as described in Experimental Procedures. The data 
are the pooled results of two experiments• Time course of inactivation of 
control membranes (4.64 mg/ml )  assayed with 200 p.M Q1 (~)  or 180 
/zM MB ([3) as electron acceptor. Specific activities were 0.124 
/xmolmin -1 mg -1 to Q1 and 0.184 p, molmin-  1 mg -1, to MB. (O, v )  
Time course of inactivation of DABS-treated membranes (4.5 mg mem- 
brane protein per ml) assayed with 200/xM Q1 (O)  or 180/zM MB (• )  
as electron acceptor. Specific activities were 0.13 /zmolmin -1 mg -1 to 
Q1 and 0.20 /zmolmin -1 mg -1, to MB. 
reaction was conducted in an O2-containing atmosphere, 
H2-Q 1 activity showed a rapid phase of DABS-dependent 
inactivation (tl/2 ~ 1 min), followed by a period of 
prolonged stability (Fig. 6). In contrast, H2-MB activity 
was much more stable to DABS inactivation under these 
(oxygen-incubated) conditions, as was previously observed 
[29]. DABS inhibition therefore causes rapid alterations at 
one or more site(s) involved in H2-ubiquinone-1 activity 
but not for H2-MB activity. 
3. 7. Effects of electron acceptor on activation of hydroge- 
nase 
NiFe hydrogenases are generally isolated in an inactive 
but activatable form [44], and reductive activation of hy- 
drogenase by H 2 or other reductants has been studied with 
several of these enzymes [22,45-47]. When aerobically 
purified B. japonicum hydrogenase activity is assayed in 
the absence of dithionite, a lag phase of several minutes is 
observed prior to achieving maximal activity [14]. This 
phenomenon was observed with Q1 or MB as electron 
acceptor [14], and is further examined here. In these 
experiments, the lag phase is defined as the time prior to 
attainment of the maximal rates of H 2 uptake (Fig. 7A). At 
constant saturating concentrations of H 2 (10.7 /xM), the 
lag time prior to reaching full activation was inversely 
dependent on Q1 concentrations and was reduced but not 
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Fig. 7. Dependence of hydrogenase activation rate on electron acceptor 
concentration. Pure hydrogenase (with an activity of 6.1 p.molminmg -1
to 200 p.M Q1, and 11•2 /zmolminmg -1 to 180 /zM MB) was obtained 
following Reactive Red-120 affinity chromatography. 02 was removed 
enzymatically and assays were performed as described in 'Materials and 
Methods,' except hat reactions were initiated by addition of enzyme (2.2 
p,g). The lag time (see A) refers to the length (in min) of the non-linear 
phase in the H 2 uptake progress curve. (B) Lag time as a function of Q1 
as electron acceptor. Specific activities ranged from 1.02 /zmol min mg-1 
with 10 p.M Q1 to 6.07/xmolminmg -1 with 200/zM Q1. (C) Lag time 
as a function of MB as electron acceptor. Specific activities ranged from 
1.00 /zmolminmg -1 with 2 /.LM MB, up to 11.2 /zmolminmg -1 with 
180 p.M MB. All assays were performed at25 ~ C. 
eliminated at saturating Q1 concentration (Fig. 7B). A 
similar inverse concentration dependence was observed 
with MB as electron acceptor (Fig. 7C); however, the 
minimal lag period (at saturating electron acceptor levels) 
was significantly and reproducibly less than that with Q1 
as electron acceptor (2 min vs. 5 min in Figs. 7B and 7C, 
respectively). 
4. Discussion 
Although a good deal of data are available regarding the 
mechanism of interaction of NiFe hydrogenases with H2, 
there is a relative paucity of data on the mechanisms of 
reaction of membrane-bound hydrogenases with electron 
acceptors (see [3] and [44] for reviews). This is especially 
true for quinones, the apparent physiological electron ac- 
ceptors. Since ubiquinone functions as an electron acceptor 
of purified B. japonicum hydrogenase [14], and is known 
to function in electron transport during H 2 oxidation in 
situ [2], a systematic study of the H2-Q oxidoreductase 
activity by both purified hydrogenase and He-oxidizing 
membrane particles was undertaken. These data provide 
new evidence which indicates that exogenous quinones 
and the artificial electron acceptor MB are reduced at 
separate sites on the hydrogenase complex in situ, and 
clarifies enzymological spects of the quinone specificity 
of a bacterial NiFe hydrogenase. Such results can most 
likely be extrapolated to other hydrogen-uptake NiFe hy- 
drogenases, due to their highly-conserved nature [8]. 
4.1. Specificity of interaction of hydrogenase with quinones 
The reactivity of quinones with different head group 
structures and redox potentials was examined, and the 
kinetic parameters of ubiquinones with different length 
isoprenoid side chains were determined• Ubiquinones, the 
plastoquinone analog duroquinone, and the menaquinone 
menadione were all reduced by the enzyme, indicating a 
relatively loose specificity with regard to the structure of 
the quinone headgroup. However, the two quinones with 
the lowest redox potentials, phylloquinone and MK 4 func- 
tioned poorly as electron acceptors. Although the lack of 
reactivity of these quinones may have been due at least in 
part to their hydrophobicity and consequent insolubility in 
the assay buffer (each has a 20 carbon lipophilic side 
chain), it is more likely that they are unreactive due to 
unfavorable interaction with an electron donating redox 
center on the enzyme which is poised at a relatively high 
potential. Two pieces of data support his conclusion: [1] 
Q4, which has an identical isoprenoid chain as MK 4 but a 
midpoint redox potential 186 mV more positive (+ 110 
mV vs. -74  mV), functioned effectively as electron ac- 
ceptor with membranes, and [2] it is well established that 
artificial electron acceptors with E' 0 < 0 function poorly 
with B. japonicum hydrogenase [2]. 
Low substrate specificity with regard to the quinone 
headgroup has also been observed in other quinone-reac- 
tive enzymes, but has not been previously observed for any 
hydrogenases. Bovine NADH-ubiquinone reductases re- 
duce rhodoquinone and duroquinone [48,49], and both 
duro- and menaquinol are oxidized by the mitochondrial 
ubiquinol-cytochrome c oxidoreductase (Complex III) 
[50,51]. Benzoquinones, naphthoquinones and anthra- 
quinones can also be incorporated into bacterial photo- 
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synthetic reaction center depleted of the 'Qa' quinone, 
where they function to oxidize the 'special pair' bacterio- 
chlorophylls [52]. The effect of substituents on the 1,4- 
benzoquinone ring on ubiquinone reduction and oxidation 
in the succinate-cytochrome c r gion has also been studied 
by the use of synthetic decyl-ubiquinone d rivatives substi- 
tuted in the 2, 3, and 5 positions of the ring [53]. Substrate 
specificity was relatively loose for quinol-cytochrome c 
reductase, but somewhat stricter for succinate-ubiquinone 
reductase. It is clear from previous reports in the literature 
that although specificity of quinone-reactive enzymes can 
be quite loose with regard to the head group, some degree 
of structural specificity occurs [49,51,53,54]. 
The membrane bound respiratory chain of B. japon- 
icum is branched, terminating with at least two terminal 
cytochrome oxidases, cytochromes aa 3 and o [2]. Since B. 
japonicum and other aerobic bacteria contain ubiquinone 
but no menaquinone [55,56], there is no need for hydroge- 
nases from these organisms to reduce a lower redox poten- 
tial substrate. The situation is different, however, in bacte- 
ria which carry out anaerobic HE-fumarate respiration, 
such as W. succinogenes [57] and E. coli [58]. 
Menaquinone, not ubiquinone, functions in HE-linked elec- 
tron transport in vivo in these organisms, and membrane- 
bound and purified hydrogenases from these organisms 
react effectively with low potential electron acceptors such 
as benzyl viologen, DMN and even the hydrophobic phyl- 
loquinone [15,57,59]. These differences among hydroge- 
nases in electron acceptor specificity based on redox po- 
tential have not been sufficiently addressed in the litera- 
ture. It is likely that homologous hydrogenases in different 
organisms which use different quinones have subtle yet 
important differences in their quinone-reactive sites and 
intramolecular electron transport mechanisms, despite their 
overall structural similarities. Subtle differences between 
homologous quinone-reactive enzymes have been observed 
among succinate-quinone reductases [60,61], fumarate re- 
ductases [61], and among bacterial photosynthetic reaction 
centers [62]. 
The role of the isoprenoid side chain of ubiquinone in 
the HE-Q oxidoreductase r action was investigated using 
ubiquinone homologs with different alkyl chains. All of 
the soluble ubiquinone homologs exhibited low K m values 
( < 40 p~M with membranes) indicating tight binding, and 
the K m was dramatically decreased with increasing iso- 
prenoid chain length. Similar effects were noted with 
purified heterodimeric hydrogenase, although the K m val- 
ues were significantly higher. Since QE and Q1 partition 
into hydrophobic phases to a much greater degree than Q0 
[63], this differential partitioning may play a role in the 
different apparent Km'S observed between Qo and the 
other ubiquinones with membranes (Table 3). Differential 
partition coefficients do not, however, explain the different 
K m values between Q1 and QE with membranes, ince 
both are expected to partition overwhelmingly into the 
lipid phase based on partition studies with model solvents 
[63]. Similarly, the partition coefficients do not explain the 
dramatically decreased K m values for longer chain 
quinones observed with purified hydrogenase. Our data 
therefore indicate that the isoprenoid side chain plays a 
crucial role in binding of ubiquinone to hydrogenase, and 
suggest hat structurally specific interactions of hydroge- 
nase with the isoprenoid side chain are likely to occur. 
Similar correlations between isoprenoid chain length of 
soluble ubiquinones and a decrease in K m (in the /xM 
range) have been observed in the case of the respiratory 
D-glucose dehydrogenases of Acinetobacter calcoaceticus 
and Gluconobacter suboxydans [64,65]. The decreased Vma x 
for pure hydrogenase observed in our experiments for QE 
(relative to Qa), as well as the lack of reactivity with Q4, 
may indicate that the quinol off-rate is the rate-limiting 
step of the catalytic ycle with pure enzyme, at least in our 
assay system. The solubility of longer chain quinones in 
the phospholipid milieu probably facilitates turnover, as 
suggested by the increased relative lectron acceptor activ- 
ity of Q2 and Q4 with membrane bound enzyme. Although 
activity of membrane-bound hydrogenase to added Q~0 
(the physiological ubiquinone in B. japonicum) was ob- 
served [55], we were unable to obtain accurate kinetic 
parameters due to the insolubility of this ubiquinone in our 
assay system. 
4.2. Ubiquinone reduction is the rate-limiting step in the 
HE-O 2 electron transport chain and is inhibited by HQNO 
and antimycin A
Since Q1H2-O2 oxidoreductase activity is inhibited by 
much lower concentrations of antimycin and HQNO then 
HE-Q 1 oxidoreductase (Fig. 1), and since myxothiazol 
inhibits the former activity but not the latter (Table 1), it is 
clear that exogenous ubiquinone reduction occurs 'up- 
stream' of the cytochrome bc I complex, presumably at the 
HE-ubiquinone oxidoreductase complex. The very similar 
concentration dependence of HQNO-induced inhibition of 
HE-Q 1 oxidoreductase activity and HQNO-induced activa- 
tion of HE-MB oxidoreductase activity (Fig. 3) also sup- 
ports this conclusion, since MB is known to accept elec- 
trons directly from hydrogenase [1-3,14]. 
Our results uggest that HE-linked ubiquinone reduction 
is the rate-limiting step in the HE-O 2 electron transport 
chain, when H E and O E are present in excess. HQNO and 
antimycin titration curves of HE-O 2 and HEQ 1 activities 
were very similar, while QIH2 activity was inhibited at 
significantly lower concentrations of both inhibitors (Fig. 
1). Therefore, the partial inhibition (about 70%) of the bc 1 
complex by the lower concentrations of these inhibitors 
does not cause inhibition of OE-linked H 2 uptake (compare 
Figs. 1, 3 and 4), but inhibition of H :-quinone oxidoreduc- 
tase activity by higher levels of the inhibitors slows the 
rate of H2-O E electron transfer (Figs. 3, 4). Both HQNO 
and antimycin A have been previously demonstrated to
inhibit HE-O E respiratory activity in membranes from B. 
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japonicum free-living cells [13] and bacteroids [43]. HQNO 
inhibition curves in both cases are monophasic; and similar 
K i values of 7 /zM [13] and 5.6 /zM [43] have been 
determined for free-living cells and bacteroids, respec- 
tively. Based upon a more detailed analysis, a two-site 
model of HQNO inhibition of H 2 respiration can now be 
proposed which is consistent with the data presented here, 
the previous results on H2-1inked electron transport in B. 
japonicum [42,43,13], and with accepted models of cy- 
tochrome bq catalysis. Since turnover at the Q-reducing 
site of a H2-Q oxidoreductase complex is rate-limiting, 
HQNO inhibition at this site would account both for the 
observed monophasic inhibition curves, and inhibition of 
H2-1inked cytochrome reduction [13,42,43]. The second 
site of HQNO inhibition is at presumably center N of the 
cytochrome bq complex. Since most of the electron flux 
to 0 2 in flee-living B. japonicum membranes (about 83%) 
goes through the cytochrome bc 1 complex [34], inhibition 
at this site in membranes would account for the previously 
observed H2-1inked accumulation of quinol in HQNO-in- 
hinted B. japonicum membranes [13]. 
Although HQNO is known to inhibit both quinone 
reduction and quinol oxidation with various enzymes 
[40,66,67], antimycin A has been assumed to be a specific 
inhibitor of cytochrome bc I complexes. Our results 
demonstrate for the first time that antimycin A also in- 
hibits H2-1inked ubiquinone reduction. To our knowledge, 
these data constitute the first report of antimycin inhibition 
of quinone reduction at a primary dehydrogenase. These 
results argue for caution in interpreting antimycin inhibi- 
tion experiments with intact membrane particles: for exam- 
ple, antimycin cannot be assumed to bind only to the 
cytochrome bc I complex. 
4.3. Evidence for separate sites of reactivity in situ for 
ubiquinone and methylene blue 
Several pieces of evidence suggested that Qa and MB 
reacted at different sites in a H2-ubiquinone oxidoreduc- 
tase complex in situ. The pH profile for the two activities 
were markedly different, and both antimycin A and HQNO 
dramatically inhibited Q1 reduction but did not inhibit MB 
reduction. In addition, HQNO-induced activation of H 2 
uptake with MB as electron acceptor was observed in 
membranes; the concentration dependence was indistin- 
guishable from that for the inhibition of H2-Q 1 oxido- 
reductase (Fig. 3). Activation of hydrogenase by HQNO 
has not been previously reported, and suggests a working 
model in which HQNO binding at a quinone-reducing site 
in the enzyme complex induces a redox and/or conforma- 
tional change which increases the electron transport to MB 
at a separate site. The chemical inactivation experiments 
with DABS provide further direct evidence for separate 
sites of MB and ubiquinone reactivity in situ. H2-Q 1 
oxidoreductase activity was significantly more sensitive 
than H2-dependent MB reduction in an O2-containing at- 
mosphere (Fig. 6). This result indicates that at least one 
DABS-reactive residue exists which is necessary for elec- 
tron transfer to ubiquinone and not to MB. 
Since the kinetics data indicate that the heterodimeric 
enzyme clearly contains a high-affinity ubiquinone-reac- 
tive site, it is likely that this site has physiological signifi- 
cance. Nevertheless, ignificant differences in pH optima, 
inhibition patterns, and substrate specificity were observed 
between purified heterodimeric hydrogenase and mem- 
branes. The high affinity site for HQNO inhibition of Q1 
reduction is not present in the purified enzyme (compare 
Figs. 3 and 5), and the K m and Vma x with Q0, Q1, Q2 
differ significantly between membrane-bound and purified 
enzyme (Table 3). Differences in 0 2 inhibition of activity 
and the reductive activation of hydrogenase were also 
observed between membranes and pure hydrogenase [14]. 
These differences indicate that the purified heterodimeric 
hydrogenase differs significantly from the in situ hydroge- 
nase complex. Since a trimeric cytochrome-b-containing 
hydrogenase was recently purified from Wolinella succino- 
genes, and the putative cytochrome-b-encoding third ORF 
of hydrogenase operons is conserved in B. japonicum and 
other bacteria [15,68-74], it is likely that the heterodimeric 
hydrogenase is a portion of a trimeric or multimeric hydro- 
genase complex that functions in situ. The putative cy- 
tochrome b and/or other polypeptides may modulate reac- 
tivity with ubiquinone. In addition, the redox state and/or 
integrity of FeS clusters may differ between the purified 
heterodimeric and membrane-bound forms of the enzyme, 
resulting in altered inhibitor binding and altered reactivity 
with quinones. 
4.4. Electron acceptor binding is necessary for optimal 
reductive activation 
Reductive activation of purified NiFe-hydrogenases by 
H z has been studied in detail and is proposed to occur in 
two stages [44]. Following 0 2 removal from the inactive 
oxidized enzyme, the enzyme is reduced (by H 2) with a 
concomitant slow conformational shift to its active form. 
Several of our observations are consistent with this general 
scheme of activation. Purified B. japonicum hydrogenase, 
like other hydrogenases, i  active only in the absence of O: 
[14]. Even though the assays are performed anaerobically 
(Fig. 7), there is a lag phase prior to achieving maximal 
turnover, indicating that deoxygenation is not sufficient for 
activation. In addition to deoxygenation and reduction, 
however, the dependence of the activation rate on electron 
acceptor concentration i dicates that the activation process 
involves binding of electron acceptor and possibly enzyme 
turnover. A similar observation has been made in studies 
of the periplasmic NiFe hydrogenase from D. gigas; the 
presence of the soluble electron acceptor cytochrome c 3 
during H e-induced activation, increased the rate of enzyme 
activation and also the appearance of the 'Ni-C' EPR 
signal that is correlated with the active state [47]. 
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Dye-dependent redox cycl ing caused a greater activa- 
tion of A. eutrophus heterodimeric hydrogenase than re- 
duction alone, and could be correlated with altered EPR 
spectra [46]. Reductive activation has also been studied 
with Azotobacter vinelandii hydrogenase, where extended 
H 2 incubations resulted in increased activity and faster 
activation during assay [22]. Our observations indicate that 
activation is accelerated when either ubiquinone or artifi- 
cial electron acceptor is bound, consistent with the artifi- 
cial electron acceptor studies of D. gigas and A. eutro- 
phus hydrogenase [45-47]. In addition to electron acceptor 
binding, it is l ikely that oxidation of the enzyme by 
electron acceptor is in fact necessary for the transition 
(during turnover) to the active form of the enzyme, as 
implied by the term ' turnover activation' [22]. If this were 
the case, then ubiquinone binding might cause specific 
changes in EPR spectroscopic properties of H 2 uptake 
NiFe hydrogenases. 
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